RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..5 of 5 - per page
Order by
Treatment and Diagnosis of Cancer, Diabetes and Other Disorders Using Adrenomedullin Peptides and Antibodies
Adrenomedullin peptides and antibodies, which would be useful in the development of a therapeutic or for diagnostics use More
Use of Biological Surfactant as Anti-flammatory Agent and Tissue Preservative Solution
Cancer immunotherapy using dendritic cells, and iii) Camel recombinant antibodies for FoxP3, Mucl & CEA. More
Product enhancement of small and large molecules in a range of dosage forms
Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms More
Tackling challenges of poor solubility
Enhancing the dissolution performance of small and large molecules in a range of dosage forms More
Optimised pulmonary/nasal therapies using supercritical fluid particle engineering
Crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More
Displaying 1..5 of 5 - per page
Order by

Related Reports

Market Research Reports provided by reports.innovaro.com
The National Institute of Allergy and Infectious Diseases – Developmental Therapeutics Review – Q4 2010
Nov 2010 - 40 pages - $500
Chronic Diseases on the Rise: Personal Health Systems to Play a Key Role in Disease Management
Oct 2009 - 17 pages - $500
Infectious Diseases Pipeline Databook - November 2011
Nov 2011 - 7 pages - $3,835
Deals and alliances in infectious diseases
Jun 2006 - 1458 pages - $2,495
Epidemiology: Sepsis – The incidence of severe sepsis is on the rise due to the dramatic aging populations across the developed world
Mar 2011 - 33 pages - $5,700
Point of Care Diagnostics for Emerging Infectious Disease Threats (Market Analysis and Technical Considerations)
Oct 2011 - 150 pages - $3,500
Sepsis Global Clinical Trials Review, Q2, 2011
Jun 2011 - 74 pages - $1,000
The National Institute of Diabetes and Digestive and Kidney Diseases – Developmental Therapeutics Review – Q4 2010
Nov 2010 - 40 pages - $500
National Institute of Arthritis and Musculoskeletal and Skin Diseases – Developmental Therapeutics Review – Q4 2010
Nov 2010 - 40 pages - $500
The National Institute of Allergy and Infectious Diseases - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Mar 2011 - 32 pages - $250
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2012 Innovaro Europe Ltd Innovaro Corporation All rights reserved. Terms and Conditions | Contact us